What is real, what is hype, and what will actually change your Tuesday clinic.
The first study of the WISeR model, in JAMA Oct. 26, found targeted services fell 15 to 20 percent in six states. The injection effect faded by spring.
Final guidance released Oct. 20 and noticed in the Federal Register Oct. 21 says device-connected apps should generally be described in a drug's prescribing information, while most companion-app content will be treated as promotional labeling.
In a Beth Israel Deaconess feasibility study funded by Alphabet, Google's AMIE interviewed patients before visits while a physician watched. No conversation needed a safety stop, but the study did not test whether care improved.
In a Sept. 1 warning letter, the Food and Drug Administration said a new machine-learning model, a move to a web platform and a platform migration each required a new 510(k) for a CT vertebral fracture tool. Practices should ask whether each vendor update still matches its clearance.
FDA's Aug. 18 discussion paper floats a two-axis risk framework, competency-based premarket testing and clinician review after launch for generative AI devices. It is not guidance. Docket FDA-2026-N-7874 closes Oct. 19, and clinicians are among those FDA invited to respond.
A 50-page draft guidance on robotically-assisted surgical devices sets out nine clinical endpoints, validated training for the whole OR team and new labeling on learning curves. It is not final, and comments on docket FDA-2026-N-9505 are due Nov. 24.
The Autus Size-Adjustable Valve can be widened by balloon catheter as a child grows, and it is the first valve approved in the U.S. with polymer leaflets. The goal is fewer open-heart operations, though the long-term data are still coming.
More patients are consulting AI before they consult you. How to turn that into a better visit rather than a debate.
Ambient documentation promises to give physicians their evenings back. The early adopters say the real change is subtler, and the risks are in places most buyers are not looking.
Before the pilot, ask these questions about data, validation, workflow, and liability.
Ambient documentation tools are spreading faster than the policies meant to govern them. Groups need clear rules on consent, review, retention, and error reporting before scale, not after.
Imaging and pathology adopted clinical AI earlier than most of medicine. Their experience offers practical lessons on worklists, validation, and the limits of algorithmic triage for every specialty.
Patient portal messages have become a second, unscheduled clinic. AI triage and drafting tools can help, but only if practices redesign the workflow around them rather than bolt them on.
Connected devices can extend care between visits, but many programs stall on alert fatigue, staffing gaps, and unclear ownership. Build the response workflow before you order the devices.
Cyberattacks on health care organizations now disrupt care, not just computers. Physicians need a downtime plan that has been practiced, printed, and understood before the screens go dark.
Young health technology companies court physician groups for pilots, data, and credibility. A careful evaluation of the business, not just the product, protects your patients and your name.
Online scheduling, chat, and intake tools promise easier access for patients. Without matching changes in staffing, templates, and follow through, they simply move frustration to a new screen.
Payers and practices are both deploying algorithms in prior authorization and claims review. Understanding what those systems see, and what they miss, changes how you document and appeal.
By our count the AMA adopted 15 policies at its Nov. 6-9 meeting, including a bar on licensing AI as a physician and EHR alerts for downcoded claims.
The FDA approved pimicotinib on Nov. 10 after a 56 percent week-25 response rate, the third CSF-1R inhibitor for TGCT and the only one dosed daily.
Orforglipron cut sleep apnea events 12 to 13 an hour more than placebo in ATTAIN-OSA, against 20 to 24 on tirzepatide's label, largely tracking weight loss.
The VA inspector general's 2026 survey found severe physician shortages at 135 of 139 facilities, with radiology, urology and anesthesiology rising most.
